Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple myeloma in the elderly

M Gautier1, H J Cohen

  • 1Dept. of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Journal of the American Geriatrics Society
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors.

Breast cancer research and treatment·2021
Same author

Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer Survivors.

Research square·2021
Same author

Race/Ethnic and Educational Disparities in the Association Between Pathogen Burden and a Laboratory-Based Cumulative Deficits Index.

Journal of racial and ethnic health disparities·2019
Same author

Investigating pathogen burden in relation to a cumulative deficits index in a representative sample of US adults.

Epidemiology and infection·2018
Same author

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

Breast cancer research and treatment·2016
Same author

Treatment of mental retardation.

Pediatric annals·2014
Same journal

Caregiver Burden at the Onset of Acute Hospital-At-Home.

Journal of the American Geriatrics Society·2026
Same journal

Utilization Patterns Among Heterogeneous Subgroups of Homebound Older Adults: A Latent Class Analysis.

Journal of the American Geriatrics Society·2026
Same journal

Off-Label Initiation of Gabapentin and Valproic Acid Among Long-Stay Nursing Home Residents With and Without Dementia.

Journal of the American Geriatrics Society·2026
Same journal

The DOAC-FRAIL Study-Same Dose, Different Story: Prevalence of Deviant Direct Oral Anticoagulant Levels in Nursing Home Residents.

Journal of the American Geriatrics Society·2026
Same journal

Practice Environment and Job Outcomes Among Primary Care Nurse Practitioners Caring for Patients With Dementia.

Journal of the American Geriatrics Society·2026
Same journal

Anticholinergic Medication Use in Veterans Affairs Long-Term Care Residents: Clinical Patterns and Opportunities for Deprescribing.

Journal of the American Geriatrics Society·2026
See all related articles

Multiple myeloma remains incurable, but new therapies offer improved disease control and quality of life. These novel treatments benefit all patients, including the elderly, by targeting drug resistance and complications.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Multiple myeloma is a generally incurable hematologic malignancy.
  • Current treatments offer disease control and improved survival but often exclude elderly patients due to high-dose therapy limitations.
  • Advances in understanding myeloma biology are driving the development of novel therapeutic strategies.

Purpose of the Study:

  • To review recent advances in multiple myeloma treatment.
  • To highlight novel therapies targeting drug resistance and disease complications.
  • To assess the applicability of these new approaches to elderly patients.

Main Methods:

  • Review of recent scientific literature on multiple myeloma.
  • Analysis of novel therapeutic strategies and their biological targets.

Related Experiment Videos

  • Evaluation of evidence regarding treatment efficacy in different patient populations, particularly the elderly.

    • Main Results:

    • Novel therapies aim to overcome drug resistance and prolong the plateau phase of the disease.
    • These therapies also focus on managing common myeloma complications like infections, anemia, and bone lesions.
    • Early evidence suggests elderly patients can benefit from these advanced treatment approaches.

    Conclusions:

    • While multiple myeloma is incurable, novel therapies offer significant improvements in disease management and quality of life.
    • These newer treatment strategies are applicable to a broader patient population, including the elderly.
    • Further research and clinical application of these advances are crucial for optimizing patient outcomes.